{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:27:53Z","timestamp":1793842073770,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12308-025-00668-0","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:47:16Z","timestamp":1762364836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validation and interpretation of the Triple A model in Turkish myeloproliferative neoplasm patients with a focus on overall and thrombosis free survival"],"prefix":"10.1007","volume":"18","author":[{"given":"Mehmet","family":"Baysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevil","family":"Sadri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcr \u00d6mer","family":"G\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serap","family":"Baysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vildan","family":"Gursoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"2","key":"668_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/bcmd.1996.0024","volume":"22","author":"VF Fairbanks","year":"1996","unstructured":"Fairbanks VF, Klee GG, Wiseman GA, Hoyer JD, Tefferi A, Petitt RM et al (1996) Measurement of blood volume and red cell mass: re-examination of 51Cr and 125I methods. Blood Cells Mol Dis 22(2):169\u2013186 (discussion 86a\u201386g)","journal-title":"Blood Cells Mol Dis"},{"issue":"1","key":"668_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/cncr.21105","volume":"104","author":"S Sirhan","year":"2005","unstructured":"Sirhan S, Fairbanks VF, Tefferi A (2005) Red cell mass and plasma volume measurements in polycythemia. Cancer 104(1):213\u2013215","journal-title":"Cancer"},{"issue":"1","key":"668_CR3","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-021-01116-z","volume":"14","author":"G Greenfield","year":"2021","unstructured":"Greenfield G, McMullin MF, Mills K (2021) Molecular pathogenesis of the myeloproliferative neoplasms. J Hematol Oncol 14(1):103","journal-title":"J Hematol Oncol"},{"issue":"3","key":"668_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4274\/tjh.galenos.2023.2023.0169","volume":"40","author":"\u0130 Yonal Hindilerden","year":"2023","unstructured":"Yonal Hindilerden \u0130, \u015eahin E, Hindilerden F, Da\u011flar Aday A, Nal\u00e7ac\u0131 M (2023) Clinical impact of JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms. Turk J Hematol 40(3):174\u2013182","journal-title":"Turk J Hematol"},{"issue":"1","key":"668_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4274\/tjh.galenos.2024.2023.0430","volume":"41","author":"Z Narl\u0131 \u00d6zdemir","year":"2024","unstructured":"Narl\u0131 \u00d6zdemir Z, \u0130pek Y, Patir P, Ermi\u015f G, \u00c7ift\u00e7iler R, \u00d6zmen D et al (2024) Impact of CALR and JAK2V617F mutations on clinical course and disease outcomes in essential thrombocythemia: a multicenter retrospective study in Turkish patients. Turk J Hematol 41(1):26\u201336","journal-title":"Turk J Hematol"},{"issue":"6","key":"668_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1182\/blood-2016-10-695940","volume":"129","author":"W Vainchenker","year":"2017","unstructured":"Vainchenker W, Kralovics R (2017) Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood 129(6):667\u2013679","journal-title":"Blood"},{"issue":"5","key":"668_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00277-019-03625-x","volume":"98","author":"M Griesshammer","year":"2019","unstructured":"Griesshammer M, Kiladjian JJ, Besses C (2019) Thromboembolic events in polycythemia vera. Ann Hematol 98(5):1071\u20131082","journal-title":"Ann Hematol"},{"issue":"3","key":"668_CR8","first-page":"167","volume":"41","author":"R Diz K\u00fc\u00e7\u00fckkaya","year":"2024","unstructured":"Diz K\u00fc\u00e7\u00fckkaya R, \u0130yig\u00fcn T, Albayrak \u00d6, Eker C, G\u00fcnel T (2024) JAK2V617F mutation in endothelial cells of patients with atherosclerotic carotid disease. Turk J Hematol 41(3):167\u2013174","journal-title":"Turk J Hematol"},{"issue":"1","key":"668_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41408-023-00972-x","volume":"14","author":"N Gangat","year":"2024","unstructured":"Gangat N, Karrar O, Al-Kali A, Begna KH, Elliott MA, Wolanskyj-Spinner AP et al (2024) One thousand patients with essential thrombocythemia: the Mayo Clinic experience. Blood Cancer J 14(1):11","journal-title":"Blood Cancer J"},{"issue":"3","key":"668_CR10","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1182\/blood.2024025459","volume":"145","author":"H Pasquer","year":"2025","unstructured":"Pasquer H, Kiladjian J-J, Benajiba L (2025) Current myeloproliferative neoplasm scoring systems for clinical practice. Blood 145(3):257\u2013276","journal-title":"Blood"},{"issue":"6","key":"668_CR11","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1182\/blood-2012-01-403279","volume":"120","author":"F Passamonti","year":"2012","unstructured":"Passamonti F, Thiele J, Girodon F, Rumi E, Carobbio A, Gisslinger H et al (2012) A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment. Blood 120(6):1197\u20131201","journal-title":"Blood"},{"issue":"4","key":"668_CR12","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/S2352-3026(22)00046-1","volume":"9","author":"M Marchetti","year":"2022","unstructured":"Marchetti M, Vannucchi AM, Griesshammer M, Harrison C, Koschmieder S, Gisslinger H et al (2022) Appropriate management of polycythaemia vera with cytoreductive drug therapy: European LeukemiaNet 2021 recommendations. Lancet Haematol 9(4):e301\u2013e311","journal-title":"Lancet Haematol"},{"issue":"4","key":"668_CR13","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/ajh.24293","volume":"91","author":"M Haider","year":"2016","unstructured":"Haider M, Gangat N, Lasho T, Abou Hussein AK, Elala YC, Hanson C et al (2016) Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients. Am J Hematol 91(4):390\u2013394","journal-title":"Am J Hematol"},{"issue":"2","key":"668_CR14","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41408-022-00625-5","volume":"12","author":"A Carobbio","year":"2022","unstructured":"Carobbio A, Vannucchi AM, De Stefano V, Masciulli A, Guglielmelli P, Loscocco GG et al (2022) Neutrophil-to-lymphocyte ratio is a novel predictor of venous thrombosis in polycythemia vera. Blood Cancer J 12(2):28","journal-title":"Blood Cancer J"},{"issue":"2","key":"668_CR15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41375-021-01410-2","volume":"36","author":"D Liu","year":"2022","unstructured":"Liu D, Li B, Xu Z, Zhang P, Qin T, Qu S et al (2022) RBC distribution width predicts thrombosis risk in polycythemia vera. Leukemia 36(2):566\u2013568","journal-title":"Leukemia"},{"issue":"1","key":"668_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41408-024-00994-z","volume":"14","author":"MK Larsen","year":"2024","unstructured":"Larsen MK, Skov V, Kj\u00e6r L, Eickhardt-Dalb\u00f8ge CS, Knudsen TA, Kristiansen MH et al (2024) Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms-a Danish longitudinal study. Blood Cancer J 14(1):28","journal-title":"Blood Cancer J"},{"issue":"12","key":"668_CR17","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/ajh.27079","volume":"98","author":"A Tefferi","year":"2023","unstructured":"Tefferi A, Loscocco GG, Farrukh F, Szuber N, Mannelli F, Pardanani A et al (2023) A globally applicable \u201ctriple A\u201d risk model for essential thrombocythemia based on age, absolute neutrophil count, and absolute lymphocyte count. Am J Hematol 98(12):1829\u20131837","journal-title":"Am J Hematol"},{"issue":"5","key":"668_CR18","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/ajh.27261","volume":"99","author":"I Krecak","year":"2024","unstructured":"Krecak I, Lekovic D, Arsenovic I, Holik H, Zekanovic I, Moric Peric M et al (2024) The triple A model (age, absolute neutrophil count, absolute lymphocyte count-AAA) predicts survival and thrombosis in polycythemia vera. Am J Hematol 99(5):989\u2013992","journal-title":"Am J Hematol"},{"key":"668_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2025.2503458","author":"D Lekovic","year":"2025","unstructured":"Lekovic D, Bogdanovic A, Arsenovic I, Ivanovic J, Cvetkovic M, Jovanovic J et al (2025) Validation of the triple A model (age, absolute neutrophil count, absolute lymphocyte count) for the prediction of survival and thrombosis in 1000 patients with polycythemia vera. Leuk Lymphoma. https:\/\/doi.org\/10.1080\/10428194.2025.2503458","journal-title":"Leuk Lymphoma"},{"issue":"20","key":"668_CR20","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127(20):2391\u20132405","journal-title":"Blood"},{"issue":"7","key":"668_CR21","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF et al (2022) The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia 36(7):1703\u20131719","journal-title":"Leukemia"},{"key":"668_CR22","doi-asserted-by":"crossref","unstructured":"Barbui T, Vannucchi AM, Buxhofer-Ausch V, De Stefano V, Betti S, Rambaldi A et al (2015) Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia. Blood Cancer J 5(11):e369\u2013e","DOI":"10.1038\/bcj.2015.94"},{"issue":"1","key":"668_CR23","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M14-0698","volume":"162","author":"KG Moons","year":"2015","unstructured":"Moons KG, Altman DG, Reitsma JB, Ioannidis JP, Macaskill P, Steyerberg EW et al (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 162(1):W1-73","journal-title":"Ann Intern Med"},{"issue":"2","key":"668_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41375-023-02114-5","volume":"38","author":"H Pasquer","year":"2024","unstructured":"Pasquer H, Daltro de Oliveira R, Vasseur L, Soret-Dulphy J, Maslah N, Zhao LP et al (2024) Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification. Leukemia. 38(2):326\u2013339","journal-title":"Leukemia."},{"issue":"1","key":"668_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41408-024-01151-2","volume":"14","author":"L Tosoni","year":"2024","unstructured":"Tosoni L, Morelli GL, Tomadini G, Lazzarotto D, Fili C, Simeone E et al (2024) The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia. Blood Cancer J 14(1):169","journal-title":"Blood Cancer J"},{"issue":"1","key":"668_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41408-023-00968-7","volume":"14","author":"GG Loscocco","year":"2024","unstructured":"Loscocco GG, Gesullo F, Capecchi G, Atanasio A, Maccari C, Mannelli F et al (2024) One thousand patients with essential thrombocythemia: the Florence-CRIMM experience. Blood Cancer J 14(1):10","journal-title":"Blood Cancer J"},{"key":"668_CR27","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2025.2521401","author":"I Arsenovic","year":"2025","unstructured":"Arsenovic I, Milic N, Grubor N, Jovanovic J, Krecak I, Lucijanic M et al (2025) Thrombo-vera: a new thrombosis risk model for polycythemia vera using modern variable selection methods. Expert Rev Hematol. https:\/\/doi.org\/10.1080\/17474086.2025.2521401","journal-title":"Expert Rev Hematol"},{"issue":"6","key":"668_CR28","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1007\/s00277-024-05751-7","volume":"103","author":"M Lucijanic","year":"2024","unstructured":"Lucijanic M, Krecak I, Galusic D, Holik H, Perisa V, Moric Peric M et al (2024) Triple A score (AAA: age, absolute neutrophil count and absolute lymphocyte count) and its prognostic utility in patients with overt fibrotic and prefibrotic myelofibrosis. Ann Hematol 103(6):2157\u20132159","journal-title":"Ann Hematol"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00668-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-025-00668-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:05:13Z","timestamp":1793840713000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-025-00668-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1007\/s12308-025-00668-0","relation":{},"ISSN":["1868-9256","1865-5785"],"issn-type":[{"value":"1868-9256","type":"print"},{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Bursa City Hospital Clinical Research Ethics Committee (2024\u201317\/9).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Consent to participate\/for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"50"}}